China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
China Resources Boya Bio pharmaceutical Group Co Ltd
Gross Profit
China Resources Boya Bio pharmaceutical Group Co Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
|
Gross Profit
¥1.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
24%
|
|
Beigene Ltd
HKEX:6160
|
Gross Profit
¥14.7B
|
CAGR 3-Years
108%
|
CAGR 5-Years
67%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Gross Profit
¥5.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Gross Profit
¥4.5B
|
CAGR 3-Years
34%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Gross Profit
¥13.6B
|
CAGR 3-Years
28%
|
CAGR 5-Years
33%
|
CAGR 10-Years
40%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Gross Profit
¥1.8B
|
CAGR 3-Years
53%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
See Also
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Gross Profit?
Gross Profit
1.3B
CNY
Based on the financial report for Mar 31, 2024, China Resources Boya Bio pharmaceutical Group Co Ltd's Gross Profit amounts to 1.3B CNY.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
24%
Over the last year, the Gross Profit growth was -14%. The average annual Gross Profit growth rates for China Resources Boya Bio pharmaceutical Group Co Ltd have been -3% over the past three years , -4% over the past five years , and 24% over the past ten years .